Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 3 clinical trials
CDK4/6 Inhibition in Locally Advanced/Metastatic Chordoma

inhibitor palbociclib in patients with locally advanced/metastatic chordoma who are not candidates for standard therapy. The primary objective is disease control in patients with chordoma treated with

imatinib
metastatic chordoma
lapatinib
palbociclib
cancer chemotherapy
  • 39 views
  • 07 Jan, 2022
  • 3 locations
Cetuximab for the Treatment of Advanced Unresectable or Metastatic Chordoma

This is a multicenter, single arm, phase 2 study designed to evaluate the efficacy and safety of cetuximab for the treatment of advanced (unresectable)/metastatic, chordoma. The target patient

x-rays
metastatic chordoma
gilbert's disease
neutrophil count
ct scan
  • 0 views
  • 18 Jun, 2022
  • 1 location
A Signal Finding Phase 2 Study of Nivolumab (Anti-PD-1; BMS-936558; ONO-4538) and Relatlimab (Anti-LAG-3 Monoclonal Antibody; BMS-986016) in Patients With Advanced Chordoma

This phase II trial studies how well nivolumab and relatlimab work in treating participants with chordoma that has spread to other places in the body. Monoclonal antibodies, such as nivolumab and relatlimab, may interfere with the ability of tumor cells to grow and spread.

platelet count
metastatic chordoma
gilbert's disease
human chorionic gonadotropin
nivolumab
  • 12 views
  • 17 Oct, 2022
  • 1 location